Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Ainley

Brian Roland Ainley, Broken Arrow, OK US

Patent application numberDescriptionPublished
20100071442HIGH PRESSURE HIGH TEMPERATURE VISCOMETER - A couette viscometer used to determine the rheological properties of Newtonian or non-Newtonian solid-laden or non-solid-laden fluids used as completion or treatment fluids in oil and/or gas wells. The instrument is capable of measuring the properties of a heated, e.g., 600° F./316° C., and pressurized sample, e.g., 30,000 psig/207 MPa, at a variety of temperatures, pressures, and shear rates. The pressure vessel is mounted in the chassis of the instrument and the vessel plug containing the viscometer components and sample may be removed as an assembly. This arrangement reduces the mass of the plug assembly, eliminating the need to transport the pressure vessel and assists in separating the sample from the pressurizing fluid. Ultimately, this arrangement improves the usability, convenience and maintenance associated with operating the instrument.03-25-2010

Michael Ainley, Derby GB

Patent application numberDescriptionPublished
20120080174HEAT EXCHANGERS FOR AIR CONDITIONING SYSTEMS - In the field of heat exchangers for air conditioning systems there is a need for an improved heat exchanger which provides improved efficiency in terms of overall packaging and performance. A heat exchanger, for use in an air conditioning system of a building, including an elongate fluid conduit which has first and second elongate heat exchange fins extending laterally therefrom. Opposed faces of the first and second fins define an acute angle therebetween. The fluid conduit defines a discrete conduit body, the first fin defines a first fin body, and the second fin defines a second fin body. The conduit body is thermally coupled to at least one of the first and second fin bodies by a discrete heat exchange member.04-05-2012

William M. Ainley, Carmel, IN US

Patent application numberDescriptionPublished
20100159598In Vitro Methods for the Induction and Maintenance of Plant Cell Lines as Single Suspension Cells With Intact Cell Walls, and Transformation Thereof - The subject invention provides simple and consistent methods to break suspension cell aggregates to single cells with intact primary cell walls. The subject invention relates in part to cell separation of suspension cell aggregates cultured in medium containing pectin-degrading enzymes or tubulin de-polymerizing compounds including colchicine. The subject invention also relates to novel uses of compounds for such purposes. Another aspect of the subject invention relates to transformation of the subject, isolated cells. Such processes simplify and integrate single-cell-based transformation and selection processes into transgenic and transplastomic event-generation work processes. The subject invention also removes technical constraints and produces marker-free and uniformly expressing transgenic lines in a high throughput fashion to support various needs of animal health, biopharma, and trait and crop protection platforms.06-24-2010
20100184128PRODUCTION OF PRODUCTS OF PHARMACEUTICAL INTEREST IN PLANT CELL CULTURES - The present invention relates to transgenic plant cell cultures comprising transgenic plant cells comprising a plurality of nucleic acids heterologous to said plant, each of said nucleic acids comprising a coding sequence encoding a pharmaceutical product of interest operably linked to one or more regulatory elements for directing expression of said coding sequence in said plant cell, said nucleic acids being stably integrated at or adjacent to native rDNA of said plant cell; methods of producing the transgenic plant cell culture; and methods of producing a pharmaceutical product of interest using the transgenic plant cell culture.07-22-2010
20100261884CLOSTRIDIUM PERFRINGENS ALPHA TOXIN PROTEINS - This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic 10-14-2010
20110189775Targeted genomic alteration - Disclosed herein are methods and compositions for targeted integration and/or targeted excision of one or more sequences into a cell, for example, for expression of one or more polypeptides of interest.08-04-2011
20110191899ENGINEERED LANDING PADS FOR GENE TARGETING IN PLANTS - A method for producing a transgenic plant includes providing a nucleic acid molecule comprising at least two regions of nucleic acid sequence that lack sequence homology with genomic DNA of the plant cell, and at least two zinc finger nuclease recognition sites, wherein the at least two regions of nucleic acid sequence that lack sequence homology with genomic DNA of the plant cell flank the at least two zinc finger nuclease recognition sites. A plant cell or tissue having the nucleic acid molecule stably integrated into the genome of the plant cell is transformed. A plant is regenerated from the plant cell. Transgenic plants are produced by the method. Seeds are produced by the transgenic plants.08-04-2011
20120034697IN VITRO METHODS FOR THE INDUCTION AND MAINTENANCE OF PLANT CELL LINES AS SINGLE SUSPENSION CELLS WITH INTACT CELL WALLS, AND TRANSFORMATION THEREOF - The subject invention provides simple and consistent methods to break suspension cell aggregates to single cells with intact primary cell walls. The subject invention relates in part to cell separation of suspension cell aggregates cultured in medium containing pectin-degrading enzymes or tubulin de-polymerizing compounds including colchicine. The subject invention also relates to novel uses of compounds for such purposes. Another aspect of the subject invention relates to transformation of the subject, isolated cells. Such processes simplify and integrate single-cell-based transformation and selection processes into transgenic and transplastomic event-generation work processes. The subject invention also removes technical constraints and produces marker-free and uniformly expressing transgenic lines in a high throughput fashion to support various needs of animal health, biopharma, and trait and crop protection platforms.02-09-2012
20120060238ACTIVATION TAGGING PLATFORM FOR MAIZE, AND RESULTANT TAGGED POPULATIONS AND PLANTS - Disclosed herein is an activation tagging construct for maize, resulting tagged populations and plants. In one example, an activation tagging DNA construct includes a coding sequence for a transposase, a detectable reporter (such as anthocyanin regulatory genes B-Peru and C1) and a non-autonomous transposable T-DNA cassette. For example, the transposable T-DNA cassette is inserted into the detectable reporter encoding region such that the B-Peru and C1 genes express anthocyanins in a cell containing the maize activation tagging DNA construct only upon excision of the transposable cassette. Methods of generating a tagged population of maize plants include transforming a maize plant cell or tissue with the disclosed constructs.03-08-2012

Patent applications by William M. Ainley, Carmel, IN US

William Michael Ainley, Carmel, IN US

Patent application numberDescriptionPublished
20080253991Anti-T Cell and Autoantigen Treatment of Autoimmune Disease - The invention is directed to a new method for the treatment of new onset Type I diabetes in mammals or for the treatment of pre-Type I diabetic mammals where the method comprises administering (a) anti-T cell therapy to the mammal and administering (b) an autoantigen and optional mucosal antigen composition, wherein (a) and (b) are administered concurrently or sequentially Exemplified is a treatment using a mixture of anti-CD3 antibodies, a glutamic acid decarboxylase (GAD) autoantigen, and an immunoregulatory cytokine Canme GAD sequences are also disclosed.10-16-2008